Applicability of the New Zealand-eating behavior questionnaire to predict weight loss responses to naltrexone/bupropion: a proof-of-concept trial
These findings suggest that participants with emotional eating lost more weight after naltrexone/bupropion than those with other eating behavior phenotypes identified using the NZ-EBQ. Further trials are warranted to validate these preliminary results.Australia and New Zealand Clinical Trials Registry (ACTRN12622000703707).
Authors
- Melissa Ivey (ORCID: https://orcid.org/0000-0002-1795-5108)
- Rinki Murphy (ORCID: https://orcid.org/0000-0002-0043-2423)
- Ole Schmiedel (ORCID: https://orcid.org/0000-0003-2569-4216)
- Nishi Karunasinghe
Institutions
- University of Auckland (NZ)
Publication Details
- Journal
- Obesity Pillars
- Published
- 2025-12-05
- DOI
- https://doi.org/10.1016/j.obpill.2025.100240
- Primary Topic
- Eating Disorders and Behaviors
- Type
- article
- Field-Weighted Citation Impact
- 0.00